Product How it works Pricing Blog FAQ About Contact
Español English
EspañolEnglish
Log inCreate free account
Zimmer Biomet

Zimmer Biomet (NYSE: ZBH) insider transactions

In the twelve months to 10 November 2026, executives and directors of Zimmer Biomet reported 6 open-market sales of 17,341 shares ($1.6m) and 0 open-market purchases, by 4 people, according to the Form 4 filings they submitted to the SEC.

Latest transactions

The 20 most recent transactions in Zimmer Biomet shares reported on Form 4
DateInsiderRoleTransactionSharesPriceHeld afterFiling
1 October 2026Campbell Gary CraigPresident, AmericasOption exercise+2,368—2,368Form 4
1 October 2026Campbell Gary CraigPresident, AmericasShares withheld for tax−932$88.421,436Form 4
1 October 2026Campbell Gary CraigPresident, AmericasOption exercise+1,218—2,654Form 4
1 October 2026Campbell Gary CraigPresident, AmericasShares withheld for tax−480$88.422,174Form 4
11 September 2026Thornal Kevin RGrp Pres-Global BusinessOpen-market sale−5,691$92.950Form 4
4 September 2026Phipps Chad FSee remarks below.Open-market sale−3,000$98.3565,231Form 4
1 August 2026Thornal Kevin RGrp Pres-Global BusinessOption exercise+9,957—9,957Form 4
1 August 2026Thornal Kevin RGrp Pres-Global BusinessShares withheld for tax−4,266$92.685,691Form 4
29 May 2026Yi SangGroup President, Asia PacificOpen-market sale−4,200$82.6428,051Form 4
29 May 2026Yi SangGroup President, Asia PacificOpen-market sale−800$82.6627,251Form 4
1 April 2026Noor JehanzebSee remarks below.Option exercise+6,626—6,828Form 4
1 April 2026Noor JehanzebSee remarks below.Shares withheld for tax−1,677$90.675,151Form 4
12 March 2026Winkler LoriSVP and CHROOpen-market sale−2,650$94.6610,224Form 4
6 March 2026Phipps Chad FSee remarks below.Option exercise+4,692—68,398Form 4
6 March 2026Phipps Chad FSee remarks below.Shares withheld for tax−1,889$92.5466,509Form 4
6 March 2026Phipps Chad FSee remarks below.Option exercise+2,094—68,603Form 4
6 March 2026Phipps Chad FSee remarks below.Shares withheld for tax−843$92.5467,760Form 4
6 March 2026Upadhyay SuketuExec VP, CFOOption exercise+10,217—71,502Form 4
6 March 2026Upadhyay SuketuExec VP, CFOShares withheld for tax−4,547$92.5466,955Form 4
6 March 2026Upadhyay SuketuExec VP, CFOOption exercise+4,559—71,514Form 4

Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.

How to read the table

Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.

Where each row comes from

From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Zimmer Biomet page; the method, in data sources.

Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.